Literature DB >> 1398999

Characterization and protective properties of attenuated mutants of Salmonella choleraesuis.

S M Kelly1, B A Bosecker, R Curtiss.   

Abstract

We have constructed crp::Tn10 and cya::Tn10 Salmonella choleraesuis mutants and their fusaric acid-resistant derivatives with deletions (delta) of the Tn10 and adjacent DNA sequences and found them to be avirulent and able to induce protection against a wild-type challenge in 8-week-old BALB/c mice. Mice survived infection with the crp and cya mutants at doses of more than 7 x 10(3) times the oral (p.o.) 50% lethal dose (LD50) and more than 8 x 10(2) times the intraperitoneal LD50 of the wild-type S. choleraesuis parent. Mice vaccinated with attenuated strains were protected against challenge with more than 1.6 x 10(4) times the p.o. LD50 and more than 80 times the intraperitoneal LD50 of the wild-type virulent S. choleraesuis parent. One deletion mutation isolated in the crp region extends to an adjacent gene(s) that was shown to be associated with avirulence. This gene or operon has been designated cdt (colonization of deep tissues). A delta (crp-cdt)19 strain, when complemented with the wild-type crp gene and promoter on a pBR-derived plasmid, had p.o. LD50 values 10(3) times higher than those for the wild type. A delta cya delta (crp-cdt)19 double mutant was less virulent than and afforded more complete protection against a challenge with the wild-type strain than a delta crp-11 delta cya double mutant or the individual cya, crp, or crp+/cdt mutants. The deletion derivatives exhibited reduced invasion of CHO cells in vitro, and the numbers of the mutants recovered from mouse tissues were less than that of the parent strain. These studies suggest that one or more of the genes involved in cell attachment to and/or invasion of S. choleraesuis may be under catabolite repression. In addition, we describe a new deletion of a gene(s) located in the crp region between cysG and argD that is associated with virulence in S. choleraesuis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398999      PMCID: PMC258244          DOI: 10.1128/iai.60.11.4881-4890.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Linkage map of Salmonella typhimurium, edition VII.

Authors:  K E Sanderson; J R Roth
Journal:  Microbiol Rev       Date:  1988-12

2.  Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains.

Authors:  J E Galán; K Nakayama; R Curtiss
Journal:  Gene       Date:  1990-09-28       Impact factor: 3.688

3.  Construction of defined galE mutants of Salmonella for use as vaccines.

Authors:  D Hone; R Morona; S Attridge; J Hackett
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

4.  Transport of trehalose in Salmonella typhimurium.

Authors:  P W Postma; H G Keizer; P Koolwijk
Journal:  J Bacteriol       Date:  1986-12       Impact factor: 3.490

5.  Cloning and DNA sequence analysis of the wild-type and mutant cyclic AMP receptor protein genes from Salmonella typhimurium.

Authors:  C J Schroeder; W J Dobrogosz
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

6.  Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium.

Authors:  W C McFarland; B A Stocker
Journal:  Microb Pathog       Date:  1987-08       Impact factor: 3.738

7.  Conservation of Salmonella typhimurium virulence plasmid maintenance regions among Salmonella serovars as a basis for plasmid curing.

Authors:  S A Tinge; R Curtiss
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

8.  Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells.

Authors:  J E Galán; R Curtiss
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis.

Authors:  N A Nnalue; B A Stocker
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

10.  A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells.

Authors:  P I Fields; E A Groisman; F Heffron
Journal:  Science       Date:  1989-02-24       Impact factor: 47.728

View more
  27 in total

1.  Salmonella enterica serovar Choleraesuis infection of the porcine jejunal Peyer's patch rapidly induces IL-1beta and IL-8 expression.

Authors:  Kendra A Hyland; David R Brown; Michael P Murtaugh
Journal:  Vet Immunol Immunopathol       Date:  2005-08-22       Impact factor: 2.046

Review 2.  Live attenuated vaccines for invasive Salmonella infections.

Authors:  Sharon M Tennant; Myron M Levine
Journal:  Vaccine       Date:  2015-04-19       Impact factor: 3.641

3.  Attenuation and immunogenicity of Deltacya Deltacrp derivatives of Salmonella choleraesuis in pigs.

Authors:  M J Kennedy; R J Yancey; M S Sanchez; R A Rzepkowski; S M Kelly; R Curtiss
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Novel attenuated Salmonella enterica serovar Choleraesuis strains as live vaccine candidates generated by signature-tagged mutagenesis.

Authors:  Yu-We Ku; Sean P McDonough; Raghavan U M Palaniappan; Chao-Fu Chang; Yung-Fu Chang
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 5.  Salmonella Serogroup C: Current Status of Vaccines and Why They Are Needed.

Authors:  Fabien J Fuche; Ousmane Sow; Raphael Simon; Sharon M Tennant
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

6.  A riboflavin auxotroph of Actinobacillus pleuropneumoniae is attenuated in swine.

Authors:  T E Fuller; B J Thacker; M H Mulks
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 7.  Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment.

Authors:  Cheng-Hsun Chiu; Lin-Hui Su; Chishih Chu
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Molecular and functional characterization of Salmonella enterica serovar typhimurium poxA gene: effect on attenuation of virulence and protection.

Authors:  K Kaniga; M S Compton; R Curtiss; P Sundaram
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Use of Attenuated but Metabolically Competent Salmonella as a Probiotic To Prevent or Treat Salmonella Infection.

Authors:  Anice Sabag-Daigle; Henry M Blunk; Juan F Gonzalez; Brandi L Steidley; Prosper N Boyaka; Brian M M Ahmer
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

10.  Mutations in the Salmonella enterica serovar Choleraesuis cAMP-receptor protein gene lead to functional defects in the SPI-1 Type III secretion system.

Authors:  Zeng-Weng Chen; Shih-Ling Hsuan; Jiunn-Wang Liao; Ter-Hsin Chen; Chi-Ming Wu; Wei-Cheng Lee; Cheng-Chung Lin; Chih-Ming Liao; Kuang-Sheng Yeh; James R Winton; Chienjin Huang; Maw-Sheng Chien
Journal:  Vet Res       Date:  2009-09-24       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.